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References, pg. 38 Figure 1 . High-throughput screen for natural product inhibitors of UPEC growth in ironrestricted environments. (a) Primary screen: 98, 384-well plates containing natural product extracts (NPEs) were screened for wells that inhibited the growth of wildtype UPEC in low iron medium (MOPS-Fe). Each dot represents a single well reaction on the x-axis and the percent plate (y-axis) represents the reduction of bacterial growth in each well as measured by the absorbance at 600 nm (OD600), relative to the plate average. Blue dots represent negative control (DMSO vehicle) wells and red dots represent positive control (200 mM 2,2'-dipyridyl) wells. The red line represents three standard deviations from the negative control. Setting the hit cut-off at ≥3 SD from the plate controls resulted in the identification of 2,803 hits that were prioritized for further screening. (b) Counter screen: The first 27 plates were excluded from the counter screen due to their low activity. The remaining 71 plates were assayed for iron chelating properties using the chromazural S (CAS) assay. 10 µM EDTA was used as a positive control (red dots) and the vehicle DMSO was used as a negative control (blue dots). The y-axis represents the relative iron chelation measured at 630 nm relative to the plate average. The red line represents three standard deviations from the negative control. NPEs that had iron chelation scores ≥3 SD were eliminated as hits. This further reduced the number of hits to 995 NPEs. (c) Secondary screen: The 995 hits that passed the primary and counter screens were assayed for growth inhibition properties under iron-replete conditions. Wildtype UPEC was grown in MOPS medium with 40 µM FeSO4 and growth inhibition relative to the plate average was recorded (y-axis). 10 µg/mL ciprofloxacin was used as a positive control (red dots) and the vehicle DMSO was used as a negative control (blue dots). Setting the hit cut-off at <3 SD (red line) from the plate negative controls narrowed the hit list to 989 NPEs. After the counter and secondary screens were completed, the list of hits was further narrowed to only include those NPEs that inhibited UPEC growth by ≥90%. This resulted in the identification of 204 hits (0.55% final hit rate).
Figures

Figure 2. Representative HPLC chromatograms. (a)
The 75% v/v water/methanol preparative C18 fraction (ESI Fig. 3 ) was purified using a reverse phase (RP) C18 column and water/methanol gradient on a Shimadzu HPLC. (b) HPLC fraction 9 was purified using an RP phenyl-hexyl column and an isocratic method (30% v/v methanol/water in water) on a Shimadzu HPLC. The absorbance at 220 nm in kilo absorbance units (kAU) is plotted on the left y-axis (solid black line). The percent volume of methanol is shown on the right y-axis (dotted black line). Collected fractions are indicated by dashed gray lines and the corresponding fraction number is indicated in italics. All HPLC fractions were tested for bioactivity (select fractions shown in ESI Fig. 4 ). Figure 11 . gCOSY NMR spectrum of nicoyamycin A recorded at 600 MHz in CD3OD. Figure 19 . gHSQCAD NMR spectrum of desferrioxamine X7 recorded at 600 MHz in CD3OD. 
Materials and Methods
Strains and culture conditions
Uropathogenic E. coli strain CFT073 was isolated from the blood and urine of a hospitalized patient diagnosed with acute pyelonephritis in the 1980s and the unmodified wildtype 
High-throughput screen
The natural product extract (NPE) library housed at the University of Michigan Center for Chemical Genomics contained ~33,000 extracts at the time of the screen. The NPEs were isolated from marine Streptomyces isolates collect from Costa Rica, Panama, and Papua New Guinea and the preparation of the extracts has been described previously. 2 The HTS was executed as described previously, 4 except that wildtype CFT073 was used instead of CFT073 tolC::kan, and accordingly, no antibiotics were included in the MOPS-Fe medium. 50 nL of NPE was spotted into each well using a Mosquito X1 hit-picking liquid handler (TTP Labtech). The Z'-factor was calculated for each plate and averaged, as previously described. 5 The average plate Z'-factor for the primary screen was 0.75±0.08, enabling outstanding signal-tonoise differentiation. 5 NPEs that inhibited CFT073 growth greater than three standard deviations from the average OD600 of the negative control wells were considered hits.
Due to the prevalence of NPEs that chelated iron, a counter screen for iron chelation was run in parallel to the primary screen for NPEs that inhibit UPEC growth in low iron medium. The chrome azurol S (CAS) shuttle assay 6 was used to quantify iron chelation, as described previously in a 384-well format. 4 50 nL of NPE was spotted into each well using a Mosquito X1 hit-picking liquid handler (TTP Labtech). The NPEs that reduced the absorbance at 630 nm by more than three standard deviations as compared to the negative controls were eliminated as iron chelators. The average plate Z'-factor was 0.52±0.07. 5
Counter screen
The 995 hits that inhibited UPEC growth in MOPS-Fe, but did not appreciably chelate iron were cherry picked from the library for confirmation in triplicate growth assays. 50 nL were pin tooled into 384 well plates and 40 μl of CFT073 in MOPS-Fe were added to the wells and assessed for the ability to inhibit bacterial growth. A secondary screen was simultaneously executed to ensure that hits were specifically inhibiting growth in low iron; the 995 hits were inoculated with 40 μl of CFT073 in MOPS-Fe with 40 µM FeSO4 added back to the medium. DMSO was used as a negative control and 10 μg/mL of ciprofloxacin was used as a positive control. The average plate Z'-factor was 0.72±0.07. 5 Six NPEs were eliminated since they inhibited the growth of CFT073 in the presence of iron more than three standard deviations from the OD600 of the negative control wells.
The 989 hits were prioritized based on their percent of growth inhibition relative to DMSOtreated CFT073. 204 NPEs inhibited the growth to ≥90% of the vehicle controls. A list of Streptomyces isolates that produced the 204 NPEs was compiled and prioritized based on the activity of the NPEs in the HTS, if the strain produced multiple active wells, and what other strains were co-isolated from the sediment. Thirty-eight Streptomyces strains were revived on oatmeal agar plates and the NPEs from a 100 mL fermentation screened for bioactivity.
Hit confirmation of S. nicoyae
A sterile inoculating loop was used to scrape the spores from an oatmeal plate and inoculate 3 mL of ISP2 medium (1% w/v malt extract, 0.4% w/v yeast extract, 0.4% w/v dextrose, 3% w/v NaCl) in aeration tubes with shaking at 200 rpm and 28ºC for seven days. 100 mL of ISP2 in a 250 mL baffled flask was inoculated with the 3 mL of starter culture and grown at 200 rpm and 28ºC for four days. The culture was pelleted at 9000 x g for 15 min. The flask was rinsed with distilled water and the supernatants were transferred back to the empty flask. Two 2 g satchets of 
HPLC Purification
All HPLC was performed with a Shimadzu LC-20AT HPLC system with an FRC-10A fraction collector. Gradient RP-HPLC was performed using Econosil C18 HPLC column with a pore size of 10 μm and dimensions of 250 x 20 mm (P/N 6251). The 75% v/v water/methanol fraction from the preparative C18 purification was prepared at 300 mg/mL in methanol and clarified by centrifugation. The column was equilibrated in 30% v/v methanol/water with a flow rate of 7 mL/min. After injecting the sample, the mobile phase remained 30% v/v methanol/water for 2 min and then increased to 80% v/v methanol/water over 40 min. The mobile phase was then increased to 95% v/v methanol/water over 3 min and then returned to 30% v/v methanol/water and maintained for 10 min.
Isocratic RP-HPLC was performed using Luna 5 μm phenyl-hexyl HPLC column with a pore size 100 Å and dimensions of 250 x 20 mm (P/N 00G-4257-N0). The fraction 9 from the gradient HPLC purification was prepared at 20 mg/mL in 4:1 methanol:water and clarified by centrifugation. The column was equilibrated in 30% v/v methanol/water with a flow rate of 3.5 mL/min. After injecting the sample, the mobile phase remained 30% methanol for 80 min, then increased to 80% v/v methanol/water over 5 min, and then returned to 30% v/v methanol/water and maintained for 10 min. DesX1 eluted in a mixture at 50 min from this isocratic RP-HPLC method.
Fractions containing DesX1 were pooled and prepared at 10 mg/mL in 30% v/v methanol/water in water for a second round of isocratic RP-HPLC using the same Luna 5 μm phenyl-hexyl HPLC column (P/N 00G-4257-N0). The column was equilibrated in 27% v/v methanol/water in water containing 0.1% v/v formic acid, with a flow rate of 3.5 mL/min. After injecting the sample, the mobile phase remained 27% v/v methanol/water for 90 min; no wash step was required.
Further analysis provided access to DesD2 and DesE, which eluted in the wash of the DesX1 and DesX7 separations using a phenyl-hexyl HPLC column. DesD2 and DesE were purified using a reverse phase C8 column with 40% v/v methanol/water and 0.1% v/v formic acid (r.t. 16 min and 24 min, respectively), and the observed elution order agrees with previous reports. 7 Their respective MS/MS fragmentation pattern and 1 H NMR spectra agree with previously published data. [7] [8] [9] 
Mass spectrometry (MS) analysis
All high-resolution ESI-MS and MS/MS spectra were collected using an Agilent 6545 Q-TOF mass spectrometer equipped with an Agilent 1290 HPLC system and 1260 detector in the Life Sciences Institute at the University of Michigan. Samples were prepared at 0.5 mg/mL in 3:2 methanol:water. 4 μl was injected onto a Luna 5 μm, C18(2) column with a pore size of 100 Å and dimensions of 100 x 2 mm (Phenomenex P/N 00D-4252-B0) equilibrated in 10% v/v methanol/water with 0.1% v/v formic acid and a flow rate of 0.4 mL/min. The column was held at 10% v/v methanol/water for 1 min and then increased to 60% v/v methanol/water for 12 min.
The column was held at 60% v/v methanol/water for 1 min and then returned to 10% v/v methanol/water and held for 2 min (16 min total run time). The MS spectra were collected in positive mode from 50-1500 m/z and stored in centroid mode. MS/MS spectra were collected in Auto MS/MS mode with a range of 50-1500 m/z for MS and 50-700 m/z for MS/MS. The fragmentor was set at 125 V and the collision energy was 40 V.
Nuclear Magnetic Resonance (NMR) analysis
All NMR spectra were acquired on a Varian INOVA 600 MHz spectrometer at the NMR Facility in the Life Sciences Institute at the University of Michigan. Molecules were dissolved in either CD3OD or DMSO-d6 and placed in a symmetrical NMR tube (Shigemi) matched to the solvent system.
